@article{afe32251753f4ddd9851e4d2526b4e6d,
title = "Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid",
keywords = "Atypical lung carcinoid, Neuroendocrine tumor, RET, RET fusion, Targeted therapeutics",
author = "Kander, \{Elizabeth M.\} and Shah, \{Manisha H.\} and Ye Zhou and Ashima Goyal and Palmer, \{Joshua D.\} and Owen, \{Dwight H.\} and Konstantin Shilo and Gopal Patel and Raval, \{Raju R.\} and Javier Gonzalez and Michele Nguyen and Elizabeth Olek and Jennifer Kherani and Rothenberg, \{S. Michael\} and Bhavana Konda",
note = "Funding Information: Dr Konda receives research funding from Bristol-Myers Squibb, Merck, Eisai, and Xencor. Dr Shah is the institutional principal investigator for Merck \& Co, Inc and LOXO Oncology; she also is an advisory board member for Eisai Inc and LOXO; and she also receives research funding from LOXO and Merck \& Co, Inc. Dr Palmer receives grant funding from Varian Medical Systems, and speaking fees from DePuy Synthes. Dr Owen is an advisory board member for AstraZeneca. Dr Nguyen, Dr Olek, Dr Kherani, and Dr Rothenberg are employees of LOXO Oncology. The remaining authors have stated that they have no conflicts of interest. Funding Information: Dr Konda receives research funding from Bristol-Myers Squibb , Merck , Eisai , and Xencor . Dr Shah is the institutional principal investigator for Merck \& Co, Inc and LOXO Oncology; she also is an advisory board member for Eisai Inc and LOXO; and she also receives research funding from LOXO and Merck \& Co, Inc . Dr Palmer receives grant funding from Varian Medical Systems , and speaking fees from DePuy Synthes. Dr Owen is an advisory board member for AstraZeneca. Dr Nguyen, Dr Olek, Dr Kherani, and Dr Rothenberg are employees of LOXO Oncology. The remaining authors have stated that they have no conflicts of interest.",
year = "2021",
month = may,
doi = "10.1016/j.cllc.2020.06.011",
language = "English",
volume = "22",
pages = "e442--e445",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
number = "3",
}